Literature DB >> 17935490

DNA microarray analyses of melanoma gene expression: a decade in the mines.

Keith S Hoek1.   

Abstract

Gene expression profiling in melanoma is an exercise in prospecting for fundamental molecular biologies useful for formulating hypotheses to explain disease characteristics. Over the last 10 years DNA microarray technologies have been employed in scores of such melanoma studies. As soon as the technology became available, researchers grasped the new tool and began to hammer away at melanoma's molecular strata. A small army of data miners toiled into the dross, believing that glittering seams of relevance had been struck and from great slag heaps of data they would extract biological gold. What exactly has a decade of ceaseless sappering brought us, what can be profitably refined from what has already been extracted and what remains undiscovered? This review is a critical analysis of the multiple research programs, which have attempted to define and contextualize broad transcriptional changes relevant to melanoma biology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17935490     DOI: 10.1111/j.1600-0749.2007.00412.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  30 in total

1.  Variability in melanoma metalloproteinase expression profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  J Biomol Tech       Date:  2010-12

2.  Activities of multiple cancer-related pathways are associated with BRAF mutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells.

Authors:  Dingxie Liu; Xuan Liu; Mingzhao Xing
Journal:  Cell Cycle       Date:  2013-10-29       Impact factor: 4.534

3.  Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery.

Authors:  Joanna Boros; Ian J Donaldson; Amanda O'Donnell; Zaneta A Odrowaz; Leo Zeef; Mathieu Lupien; Clifford A Meyer; X Shirley Liu; Myles Brown; Andrew D Sharrocks
Journal:  Genome Res       Date:  2009-08-17       Impact factor: 9.043

4.  A nine-gene signature predicting clinical outcome in cutaneous melanoma.

Authors:  G Brunner; M Reitz; A Heinecke; A Lippold; C Berking; L Suter; J Atzpodien
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-09       Impact factor: 4.553

5.  Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.

Authors:  Luca Sigalotti; Alessia Covre; Elisabetta Fratta; Giulia Parisi; Francesca Colizzi; Aurora Rizzo; Riccardo Danielli; Hugues J M Nicolay; Sandra Coral; Michele Maio
Journal:  J Transl Med       Date:  2010-06-11       Impact factor: 5.531

6.  Identification of genomic locus responsible for experimentally induced testicular teratoma 1 (ett1) on mouse Chr 18.

Authors:  Takehiro Miyazaki; Yoshie Ikeda; Ikue Kubo; Saeri Suganuma; Nastumi Fujita; Makiko Itakura; Tae Hayashi; Shuji Takabayashi; Hideki Katoh; Yukio Ohira; Masahiro Sato; Motoko Noguchi; Toshinobu Tokumoto
Journal:  Mamm Genome       Date:  2014-07-05       Impact factor: 2.957

Review 7.  Malignant melanoma in the 21st century: the emerging molecular landscape.

Authors:  Aleksandar Sekulic; Paul Haluska; Arlo J Miller; Josep Genebriera De Lamo; Samuel Ejadi; Jose S Pulido; Diva R Salomao; Erik C Thorland; Richard G Vile; David L Swanson; Barbara A Pockaj; Susan D Laman; Mark R Pittelkow; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2008-07       Impact factor: 7.616

Review 8.  Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

Authors:  Bonnie E Gould Rothberg; Michael B Bracken; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

9.  Molecular markers of tumor progression in melanoma.

Authors:  Joshua Rother; Dan Jones
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

Review 10.  Biomarkers in melanoma.

Authors:  H Gogas; A M M Eggermont; A Hauschild; P Hersey; P Mohr; D Schadendorf; A Spatz; R Dummer
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.